These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 6541449)
1. Disposition of [14C]aztreonam in rats, dogs, and monkeys. Kripalani KJ; Singhvi SM; Weinstein SH; Everett DW; Bathala MS; Dean AV; Ita CE; Lawrence L; Meeker FS; Shaw JM Antimicrob Agents Chemother; 1984 Aug; 26(2):119-26. PubMed ID: 6541449 [TBL] [Abstract][Full Text] [Related]
2. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys. Kita Y; Fugono T; Imada A Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and pharmacokinetics of aztreonam in healthy subjects. Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys. Nonaka K; Tsujioka T; Tougou K; Mukai H Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys. Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385 [TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences. Lan SJ; El-Hawey AM; Dean AV; Schreiber EC Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys. Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785 [TBL] [Abstract][Full Text] [Related]
14. Distribution of [14C]aztreonam in rat tissue. Singhvi SM; Ita CE; Shaw JM; Migdalof BH Antimicrob Agents Chemother; 1984 Aug; 26(2):127-31. PubMed ID: 6541450 [TBL] [Abstract][Full Text] [Related]
15. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey. Bechtel WD; Mierau J; Richter I; Stiasni M Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
17. The disposition and urinary metabolism of 14C-labelled FCE 22891, a pro-drug of FCE 22101, in animals. Battaglia R; Benedetti MS; Frigerio E; Vicario G; Roncucci R J Antimicrob Chemother; 1990 Jan; 25(1):133-9. PubMed ID: 2318748 [TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
20. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]